相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Store at -20˚C
- 英文名:
Recombinant Human Annexin A4(ANXA4)
- 库存:
详询
- 供应商:
南京莱富赛
- 规格:
详询
host_species:E.coli
purification:Greater than 85% as determined by SDS-PAGE.
other_names:35-beta calcimedin Annexin IV Annexin-4 Carbohydrate-binding protein p33,p41 Chromobindin-4 Endonexin I Lipocortin IV P32.5 PP4-X Placental anticoagulant protein II
accession_no:P09525
calculated_mw:55.8 kDa
tag info:N-terminal 10xHis-SUMO-tagged and C-terminal Myc-tagged
Immunogen Description:Expression Region:2-319aa
Sequence Info:Full Length
formulation:Tris-based buffer50% glycerol
storage:The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself. Generally, the shelf life of liquid form is 6 months at -20℃,-80℃. The shelf life of lyophilized form is 12 months at -20℃,-80℃.
Notes:Repeated freezing and thawing is not recommended. Store working aliquots at 4℃ for up to one week.
background:Calcium,phospholipid-binding protein which promotes membrane fusion and is involved in exocytosis.
产品详细信息请点击:Recombinant Human Annexin A4(ANXA4)
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验99mTc-Annexin A5 Uptake and Imaging to Monitor Chemosensitivity
for monitoring tumor chemosensitivity on a daily basis. Recent developments in molecular imaging have allowed the synthesis of a new radiolabeled agent, 99m Tc-recombinant human Annexin A5, designed to the assessment of apoptotic response of cancers
In Vitro Identification of UDP-Glucuronosyltransferases (UGTs) Involved in Drug Metabolism
in the prediction of adverse reactions resulting from drug-drug interactions or genetic polymorphism. An integrated approach is proposed for UGT reaction phenotyping using recombinant enzymes and human liver microsomes. Described methods include screening
In Vitro Identification of Cytochrome P450 Enzymes Responsible for Drug Metabolism
for the prediction of adverse reactions caused by drug–drug interactions or individual genetic polymorphism. An integrated approach is described for CYP-mediated metabolic reaction phenotyping using both recombinant enzymes and human liver microsomes in combination
技术资料暂无技术资料 索取技术资料







